Ezetimibe is a nonstatin low-density lipoprotein cholesterol-lowering small molecule drug. Ezetimibe is the only currently FDA-approved approved member of the of intestinal cholesterol reuptake ...

will be used to support regulatory and approval filings for the 10 mg obicetrapib and 10 mg ezetimibe fixed-dose combination treatment for patients already using maximally tolerated lipid-lowering ...

In clinical practice, a combination of drugs is often used to treat patients with dyslipidemia who are not achieving their treatment goals. Ezetimibe reduces LDL cholesterol levels, and niacin ...